A new study from the University of Zurich identified immune system
patterns in people with MS that may be clues to how MS is triggered. The
MS Twin Study – 61 sets of identical twins in which only one twin had
MS – is a unique opportunity to study early biological events in MS.
Twins have identical genes, so this allows researchers to distinguish
other non-genetic differences that may underlie MS.
In this study, researchers used state-of-the-art technologies such as mass cytometry (exploring millions of cells) and machine learning (an automated type of data analysis) to look at the immune profiles of these sets of twins. The results showed key differences in docking sites on immune messenger proteins (cytokines), that affect how immune cells communicate with each other. These differences left people with MS susceptible to greater activation of the cells that drive immune attacks in MS.
Although twins do share early environmental experiences (such as prenatal influences), these results suggest that a later environmental factor or factors might be at play. Ongoing research by scientists around the world are working on identifying those factors and how they launch the disease.
Read more from the University of Zurich
Read the paper, available from Nature via Open Access
In this study, researchers used state-of-the-art technologies such as mass cytometry (exploring millions of cells) and machine learning (an automated type of data analysis) to look at the immune profiles of these sets of twins. The results showed key differences in docking sites on immune messenger proteins (cytokines), that affect how immune cells communicate with each other. These differences left people with MS susceptible to greater activation of the cells that drive immune attacks in MS.
Although twins do share early environmental experiences (such as prenatal influences), these results suggest that a later environmental factor or factors might be at play. Ongoing research by scientists around the world are working on identifying those factors and how they launch the disease.
Read more from the University of Zurich
Read the paper, available from Nature via Open Access
No comments:
Post a Comment